Sost Biotech Showcases Innovative NAD+ Derivatives At FIC Guangzhou 2025
Nov 28, 2025
Leave a message
In Novmber 2025, the highly anticipated Guangzhou International Natural Extracts and Health Food Ingredients Exhibition(FIC Guangzhou) grandly opened at the Guangzhou Pazhou Convention and Exhibition Center. As a leading player in China's biotechnology field, Sost Biotech was invited to participate in this annual event, showcasing its core R&D achievements and joining global industry partners.
At this exhibition, our company highlighted its groundbreaking product line in the field of NAD+ (nicotinamide adenine dinucleotide) derivatives. As a cutting-edge ingredient in cellular energy metabolism and anti-aging research, NAD+ and its derivatives have broad application prospects in the functional supplement market. We presented a complete solution from basic raw materials to high-purity active ingredients:
| Product Name | Core Application Areas | Technical Features |
|---|---|---|
| NMNH (Nicotinamide Mononucleotide Reduced) | Anti-aging, Cell Repair | High stability, Enhanced bioavailability |
| NRCL Nicotinamide Riboside Chloride | Energy Supplement, Sports Nutrition | Rapid absorption, Optimized water solubility |
| NAD+ (Nicotinamide Adenine Dinucleotide Oxidized) | Metabolism Support, Cognitive Health | Active purity ≥98% |
| NADP (Nicotinamide Adenine Dinucleotide Phosphate) | Antioxidation, Immune Regulation | Precursor of Coenzyme II |
| NADH (Nicotinamide Adenine Dinucleotide Reduced) | Fatigue Relief, Mitochondrial Function | Stabilized process |
In addition to the NAD+ series, our independently developed formulated plant extracts were also a highlight of our booth. Sourced from the Himalayas, Shilajit extract is rich in fulvic acid and various minerals, demonstrating exceptional performance in formulas that enhance male vitality and provide antioxidant benefits. Black garlic extract, produced through a fermentation and maturation process, is characterized by its high S-allyl cysteine content and is widely used in cardiovascular health and immune support products. All these raw materials have undergone rigorous quality system certification and comply with regulations and standards in multiple countries.
Leveraging fifteen years of industry experience, Sost Biotech has built a comprehensive service system from R&D to production. We support one-stop OEM processing services, covering raw material procurement, formulation design, process optimization, and large-scale production; we offer personalized formulation sampling services, responding to customer needs in as little as 7 business days; and we can scientifically blend multiple ingredients and flexibly output various dosage forms such as capsules, powders, and tablets to meet the market positioning and consumption scenarios of different brands.
During the exhibition, we engaged in in-depth exchanges with representatives from over 100 companies from North America, Europe, and the Asia-Pacific region. To deepen strategic cooperation and achieve win-win development, we promise to provide all on-site clients with the most competitive pricing and priority production scheduling. We believe that collaborations based on cost advantages and quality assurance will create sustainable value growth for our clients.
FIC Guangzhou 2025 is not only a platform for product display but also a bridge for the exchange of ideas. We sincerely thank every partner and industry colleague who visited the Sost Biotech booth. In the future, the company will continue to increase its R&D investment and expand its global certification network to help clients upgrade their brands with more innovative and reliable solutions. We look forward to meeting you again at the next FIC event to discuss the new future of the health industry!
Contact Email:info@sostherbusa.com
Send Inquiry